Skip to main content
SpringerLink
Log in

Pharmacological evaluation of rat paw oedema induced byBothrops jararaca venom

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The mechanism involved in the genesis of the rat paw oedema caused by intraplantar (IPL) injection ofBothrops jararaca venom (BJV) has been investigated. IPL injection of BJV (1 to 30 μg/paw) caused a dose- and time-related oedematogenic effect. Oedema was maximal within 1 h after BJV injection, was partially reduced at 6 h and disappeared completely within 24 h. No systemic effect was observed. Previous heating of BJV at 100°C for 3 to 30 min caused a significant inhibition (25%) of its oedematogenic activity. Daily IPL injections of BJV (10 μg/paw) for 4 days attenuated BJV-induced oedema (26%), but did not influence oedema-induced by PAF-acether, serotonin (5-HT) and histamine (His), indicating the absence of cross desensitization. In the paw desensitized by daily IPL injections of PAF-acether, BJV induced a full oedematogenic response also indicating absence of cross desensitization. Different groups of drugs including α1- and α2-adrenoceptor antagonists (prazosin and yohimbine), inhibitors of both cyclo- and lipo-oxygenase (indomethacin, nordihydroguaiaretic acid), inhibitors of phospholiase A2 (dexamethasone and mepacrine) caused marked inhibition of BJV-induced rat paw oedema, whereas antagonists of 5-HT, PAF-acether and H1-histamine receptors were less effective. Pre-treatment with a β-adrenoceptor antagonist, a Ca2+ channel blocker and a H2-histamine antagonist failed to affect BJV-induced oedema. Pre-treatment of the animals with captopril did not interfere with BJV-induce oedema, suggesting that kinins are not insolved in the genesis of oedema. Association of BJV with 5-HT and PAF did not potentiate the BJV-induced oedema. It is concluded that BJV-induced rat paw oedema appears to be mediated primarily by cycloxygenase and lipoxygenase eicosanoid products and activation of α1- and α2-adrenoceptors, while HIS, 5-HT and PAF-acether appear to exert minor roles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S. A. Minton Jr.,Snakes and snake venoms. InVenom diseases, pp. 107–108, Thomas Springfield 1974.

    Google Scholar 

  2. F. R. Mandelbaum, A. P. Reichel and M. T. Assakura,Isolation and characterization of a proteolitic enzyme from the venom of the snake Bothrops jararaca (jararaca). Toxicon20, 955–972 (1982).

    Article  PubMed  Google Scholar 

  3. C. P. S. Amaral, O. A. da Silva, P. Godoy and D. Miranda,Renal cortical necrosis following Bothrops jararaca and B. jararacussu snake bite, Toxicon23, 877–885 (1985).

    Article  PubMed  Google Scholar 

  4. I. L. Bonta,Microvascular lesions as a target of antiinflammatory and certain other drugs. Acta Physiol Pharmacol. Neerl.15, 188–222 (1969).

    PubMed  Google Scholar 

  5. B. B. Vargaftig, N. Bhargava and I. L. Bonta,Haemorrhagic and permeability increasing effects of “Bothrops jararaca” and other Crotalidae venoms as related to amine or kinin release. Agents and Actions4, 163–168 (1974).

    PubMed  Google Scholar 

  6. R. C. Shaeffer, R. W. Carlson and M. H. Weil,Effects of antivenin and corticosteroid analogs on rattlesnake venom shock in the rat. J. Pharmacol. Exp. Ther.211, 409–414 (1979a).

    PubMed  Google Scholar 

  7. R. C. Shaeffer, T. R. Pattabhiraman, R. W. Carlson, F. E. Russel and M. H. Weil,Cardiovascular failure produced by a peptide from the venom of the Southern pacific rattlesnake Crotalus viridis helleri, Toxicon17, 447–453 (1979b).

    Article  PubMed  Google Scholar 

  8. A. Ohsaka,hemorrhagic necrotizing and oedema forming effects in snake venom. InSnake Venoms, Handbook of Experimental Pharamcology, vol. 52. (C. Y. Lee Ed.) p. 480, Springer, Berlin, 1979.

    Google Scholar 

  9. S. Leyck, E. Etschemberg, C. Handding and J. Winkihnan,A new model of acute inflammation: Cobra venom factor induced paw oedema. Agents and Actions73, 437–438 (1983).

    Google Scholar 

  10. E. Lomonte,Edema forming activity of Bushmater (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polivalent antivenom. Toxicon23, 173–176 (1985).

    Article  PubMed  Google Scholar 

  11. B. S. Vishwanath, R. M. Kini and T. V. Gowda,Characterization of three edema-inducing phospholipase A 2-enzymes from Habu (Trimeresurus flavovidis) venom and their interaction with the alkaloid aristolochic acid. Toxicon25, 501–515 (1987).

    Article  PubMed  Google Scholar 

  12. B. J. Hawgood,Physiological and pharmacological effects of rattlesnake venoms. InRathe snake venoms. Their actions and treatment. (Ed. Anthony I. Tu) pp. 121–162, Marrel Akker Inc., New York 1983.

    Google Scholar 

  13. A. M. Rothschild and Z. Rothschild,Liberation of pharmacologically active substances by snake venoms. InSnake Venoms. Handbook of Experimental Pharmacology, vol. 52. (Ed. C. Y. Lee) pp. 591–628, Springer, Berlin 1979.

    Google Scholar 

  14. M. Rocha e Silva, W. T. Beraldo and G. Rosenfeld,Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma by snake venoms and by trypsin. Am. J. Physiol.156, 261–273 (1949).

    Google Scholar 

  15. S. H. Ferreira,A bradykinin-potentiating factor (BPF) present in the venom of B. jararaca. Br. J. Pharmac.24, 163–165 (1965).

    Google Scholar 

  16. C. V. Winder, J. Max and M. A. Beem,Rapid foot volume measurements on unanesthetized rats and the question of a phenylbutazone effect on anaphylactoid oedema. Arch. Int. pharmacodyn.112, 147–182 (1957).

    Google Scholar 

  17. C. A. Winter, E. A. Risley and G. W. Nuss,Carrageenan induced oedema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med.111, 544–547 (1962).

    Google Scholar 

  18. U. Hamberg and M. Rocha e Silva,Release of bradykinin as related to the esterase activity of trypsin and of the venom of Bothrops jararaca, Experientia13, 489 (1957).

    PubMed  Google Scholar 

  19. R. S. B. Cordeiro, M. A. Martins, P. M. R. Silva, H. C. Castro Faria Neto, J. R. C. Castanheira and B. B. Vargaftig,Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections. Life Sci.39, 1871–1878 (1986).

    Article  PubMed  Google Scholar 

  20. P. Crunkhorn and S. C. R. Meacok,Mediators of the inflammation induced in the rat paw by carrageenin. Br. J. Pharmac.42, 392–402 (1971).

    Google Scholar 

  21. M. Di Rosa, J. P. Giroud and D. A. Willoughby,Studies of the mediators of the acute inflammatory responses induced in rats in differents sites by carrageenin and turpentine. J. Pathology.104, 15–29 (1971).

    Article  Google Scholar 

  22. J. Garcia Leme, L. Hamamura, M. P. Leite and M. Rocha e Silva.Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating. Br. J. Pharmac.48, 88–96 (1973).

    Google Scholar 

  23. K. Stochla and S. Maslinski,Carrageenin-induced oedema in the rat paw-histamine participations. Agents and Actions. 12, 201–202 (1982).

    Article  PubMed  Google Scholar 

  24. J. P. Bolam, N. P. C. Elliot, A. W. Ford-hutchinson and M. J. H. Smith,Histamine, 5-hydroxytryptamine, kinins and the anti-inflammatory activity of human plasma fraction in carrageenan induced paw oedma in the rat. J. Pharm. Pharmac.26, 434–440 (1974).

    Google Scholar 

  25. T. Mikami and K. Miyasaka,Effects of several in the antiinflammatory drugs on the various parameters involved in the inflammatory response in rat carrageenin-induced pleurisy.95, 1–12 (1983).

  26. M. M. Goldenberg and R. D. Meurer,A pharmacologic analysis of the action of platelet-activating factor in the reaction of hind-paw edema in the rat. Prostaglandins.28, 271–277 (1984).

    Article  PubMed  Google Scholar 

  27. K. F. Swingle and M. J. Reiter,Inhibition of Paf-acetherinduced edema of the rat's paw. Agents and Actions.18, 359–365 (1986).

    PubMed  Google Scholar 

  28. M. J. DiMartino, D. E. Griswold, B. A. Berkowitz, G. Poste and N. Hanna,Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipooxigenase and cyclo-oxygenase. Agents and Actions20, 113–123 (1987).

    PubMed  Google Scholar 

  29. T. J. Williams,Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br. Med. Bull.39, 239–242 (1983).

    PubMed  Google Scholar 

  30. S. D. Brain and T. J. Williams,Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmac.86, 855–860 (1985).

    Google Scholar 

  31. D. Haworth, J. R. M. Heron and F. Carey,Rat paw hyperalgesia and oedema in response to NMDA Naja naja phospholipase A2. Br. J. Pharmac.93, 145P (1988).

  32. A. M. Boctor, C. Burke and M. E. Hovinga,Arachidonic acid-induced pleurisy (ARIP): An in vivo medel for testing 5-lipoxygenase inhibition. Meth Find Exptl Clin Pharmacol.9, 793–797 (1987).

    Google Scholar 

  33. S. J. Foster, M. E. McCormik and A. Howarth,The contribution of cyclooxygenase products to acute inflammation in the rat. Agents and Actions17, 358–359 (1985).

    Google Scholar 

  34. A. Blackham, A. A. Norris, and A. M. WoodsModels for evaluating the anti-inflammatory effects of inhibitors of arachidonic acid metabolism. J. Pharm. Pharmac.37, 787–793 (1985).

    Google Scholar 

  35. J. A. Salmon, P. M. Simmons and S. Moncada,The effects of BW755CC and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumalation in experimentallyinduced acute inflammation. J. Pharm. Pharmac.35, 808–813 (1983).

    Google Scholar 

  36. M. T. Zanin and S. H. Ferreira,Relationship between oedema and plasma exudation in rat paw carrageenan inflammation. Agents and Actions8, 606–609 (1978).

    PubMed  Google Scholar 

  37. P. Braquet, L. Touqui, T. Y. Shen and B. B. Vargaftig,Perspectives in platelet-activating factor research, Pharmacol. Rev.39, 97–145 (1987).

    PubMed  Google Scholar 

  38. A. L. A. Boura and A. P. Svolmanis,Converting enzyme inhibition in the rat paw by captopril is accompained by potentiation of carrageenan-induced inflammation. J. Pharm. Dyn.7, 372–377 (1984).

    Google Scholar 

  39. H. Suda, H. Yamauchi and T. Iso,Potentiative effect of angiotensin converting enzyme inhibitor on carrageenan oedema in rats and the role of tissue kininogen. J. Pharm. Dyn.7, 372–377 (1984).

    Google Scholar 

  40. J. B. Calixto, M. Nicolau and R. A. Yunes,The selective antagonism of bradykinin action on isolated rat uterus by crude Mandevilla velutina extract. Br. J. Pharmac.85, 729–731 (1985).

    Google Scholar 

  41. J. B. Calixto, M. Nicolau, M. G. Pizzolatti and R. A. Yunes,Kinin antagonist activity of compounds from Mandevilla velutina in the isolated rat uterus. Br. J. Pharmac.91, 199–204 (1987).

    Google Scholar 

  42. J. B. Calixto and R. A. Yunes,Effects of a crude extract of Mandevilla velutina on bradykinin and [Des-Arg 9]-BK-induced contraction of isolated rabbit vessels. Br. J. Pharmac.85, 937–941 (1986).

    Google Scholar 

  43. J. B. Calixto, M. Nicolau, H. Trebien, M. G. O. Henrique, V. B. Weg, R. S. B. Cordeiro and R. A. Yunes,Antiedematogenic actions of a hydroalcoholic crude water-alcohol extract of Mandevilla velutina. Brazilian J. Med. Biol. Res.19, 575A (1986).

    Google Scholar 

  44. M. Nicolau, J. B. Calixto, M. L. Bittencourt, M. N. Beins, R. S. B. Cordeiro, M. G. O. Henrique, V. B. Weg and R. A. Yunes,Effect of Mandevilla velutina crude extracts in cutaneous rat vascular permeability and mouse carrageenan induced pleurisy. Proceedings of the French Branzilian Symposium of Chemistry and Pharmacology of Natural Substance in Inflammation, Allergy and Thrombosis. Rio de Janeiro 1986.

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology CCB, Universidade Federal de Santa Catarina, 88000, Florianópolis, SC, Brasil

    H. A. Trebien & J. B. Calixto

Authors
  1. H. A. Trebien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. B. Calixto
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

To whom all correspondence should be addressed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trebien, H.A., Calixto, J.B. Pharmacological evaluation of rat paw oedema induced byBothrops jararaca venom. Agents and Actions 26, 292–300 (1989). https://doi.org/10.1007/BF01967293

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967293

Keywords

Search

Navigation